GlassScriptPhysician profile
Arturo Hernandez
NPI 1114112141
$8,342.97
in general payments reported to CMS, 2019-2025
51 companies · $1,428 in 2025
The $1,428 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $890 · 2021: $1,599 · 2022: $855 · 2023: $742 · 2024: $1,753 · 2025: $1,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,894 · Education: $28.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,894.32 |
| Education | $28.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $930.65 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $597.74 | 2021-2025 | |
| Amgen INC. | $542.22 | 2019-2025 | Otezla, Repatha, Otezla |
| Nestle Healthcare Nutrition INC. | $509.21 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $472.04 | 2019-2025 | Farxiga, Breztri, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.35 | 2019-2024 | Jardiance |
| Abbvie INC. | $462.92 | 2021-2025 | |
| Novo Nordisk INC | $426.31 | 2019-2025 | Ozempic, Rybelsus |
| Globus Medical, INC. | $410.22 | 2025 | Senza |
| Janssen Pharmaceuticals, INC | $386.87 | 2019-2024 | Spravato, Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $320.10 | 2019-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $315.81 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $253.87 | 2024-2025 | Zenpep |
| Amarin Pharma, INC. | $193.58 | 2019-2022 | |
| Astellas Pharma US INC | $182.54 | 2019-2025 | Veozah |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.